CCIA
BLU

Campbell & Co Investment Adviser’s BELLUS Health Inc. BLU Stock Holding History

Campbell & Co Investment Adviser’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-47,383
Closed -$389K – 1084
2022
Q4 		$389K Buy
+47,383
New +$442K 0.09% 426

Other funds holding BLU

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCOC
Power Corp of Canada Montreal, Quebec, Canada $745M AUM 22.7% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Campbell & Co Investment Adviser's BLU Position: Q1 2023 in Review

Campbell & Co Investment Adviser sold out of BELLUS Health Inc. (BLU) in Q1 2023, closing a stake of 47,383 shares — an estimated $389K sold.

Campbell & Co Investment Adviser first reported a position in BLU in Q4 2022 and held it in 1 quarter. The position peaked at $389K in Q4 2022. 106 funds tracked by Wall St. Rank hold BLU as of Q1 2023.

  • Campbell & Co Investment Adviser reported no remaining BELLUS Health Inc. position as of Q1 2023 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 47,383 BELLUS Health Inc. shares in Q1 2023, an estimated $389K.
  • Campbell & Co Investment Adviser first reported a position in BELLUS Health Inc. in Q4 2022 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's BELLUS Health Inc. position peaked at $389K in Q4 2022.
  • 106 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q1 2023.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2023, filed 11 May 2023.